• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为治疗干预者和主治神经科医生的夏科

Charcot as therapeutic interventionist and treating neurologist.

作者信息

Goetz C G, Bonduelle M

机构信息

Department of Neurological Sciences, Rush University/Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL, USA.

出版信息

Neurology. 1995 Nov;45(11):2102-6. doi: 10.1212/wnl.45.11.2102.

DOI:10.1212/wnl.45.11.2102
PMID:7501168
Abstract

Although Jean-Martin Charcot's best-known medical and scientific contributions relate to anatomical-clinical correlation, he was also a highly regarded physician. His published lectures and articles, as well as documents at the Bibliothèque Charcot, demonstrate his active interest in therapeutic interventions and in bringing new experimental treatments to France for study. He investigated the efficacy of bromides for epilepsy, colchicine for gout, and ergots and anticholinergic drugs for Parkinson's disease. Nonpharmacologic treatments in which he took interest included physical rehabilitation/speech therapy, hydrotherapy, electrical stimulation of weakened muscles, isolation, and exotic interventions such as suspension and vibratory treatments with special chairs and helmets. Letters from his patients reveal an active interchange, with patients complimenting Charcot on successful treatments but also demanding more effective ones when his prescriptions did not abate their conditions. These documents demonstrate that Charcot was not a therapeutic nihilist but was particularly active in therapeutic investigations in the context of 19th-century medical science.

摘要

尽管让-马丁·夏科最著名的医学和科学贡献与解剖临床关联有关,但他也是一位备受尊敬的医生。他发表的讲座和文章,以及夏科图书馆的文献,都表明他对治疗干预以及将新的实验性治疗方法引入法国进行研究有着浓厚的兴趣。他研究了溴化物治疗癫痫、秋水仙碱治疗痛风以及麦角和抗胆碱能药物治疗帕金森病的疗效。他感兴趣的非药物治疗方法包括物理康复/言语治疗、水疗、对虚弱肌肉的电刺激、隔离,以及诸如使用特殊椅子和头盔进行悬吊和振动治疗等奇特的干预措施。他的病人来信显示出一种积极的交流,病人称赞夏科治疗成功,但当他的处方未能缓解病情时,也要求采用更有效的治疗方法。这些文献表明,夏科不是一个治疗虚无主义者,而是在19世纪医学科学的背景下积极参与治疗研究。

相似文献

1
Charcot as therapeutic interventionist and treating neurologist.作为治疗干预者和主治神经科医生的夏科
Neurology. 1995 Nov;45(11):2102-6. doi: 10.1212/wnl.45.11.2102.
2
Jean-Martin Charcot (1825-1893): A Treatment Approach Gone Astray?让-马丁·沙可(1825 - 1893):一种误入歧途的治疗方法?
Eur Neurol. 2017;78(5-6):296-306. doi: 10.1159/000481940. Epub 2017 Oct 26.
3
Jean-Martin Charcot: neurologist by avocation, nephrologist by yearning.让-马丁·沙可:神经科医生是他的业余爱好,肾病学家是他的向往。
J Nephrol. 2011 May-Jun;24 Suppl 17:S4-11. doi: 10.5301/JN.2011.6453.
4
The prefaces by Charcot: leitmotifs of an international career.夏科的序言:一段国际职业生涯的主旨
Neurology. 2003 Apr 22;60(8):1333-40. doi: 10.1212/01.wnl.0000055925.50060.64.
5
Jean-Martin Charcot and Parkinson's disease: Teaching and teaching materials.让-马丁·沙可与帕金森病:教学与教材。
Rev Neurol (Paris). 2018 Sep-Oct;174(7-8):491-505. doi: 10.1016/j.neurol.2017.08.005. Epub 2018 Apr 10.
6
Jules Joseph Dejerine: an outstanding neurologist and Charcot's enemy.朱尔斯·约瑟夫·德热里纳:一位杰出的神经学家,也是夏科的敌人。
Arq Neuropsiquiatr. 2018 May;76(5):352-354. doi: 10.1590/0004-282X20180028.
7
Broken dynasty: how Jean Batiste Charcot relinquished his father's neurological empire to conquer the seven seas.破碎的王朝:让-巴蒂斯特·沙可如何放弃父亲的神经医学帝国,征服七大洋。
Neurol Sci. 2018 Apr;39(4):765-768. doi: 10.1007/s10072-018-3258-9. Epub 2018 Jan 30.
8
Visual art in the neurologic career of Jean-Martin Charcot.让-马丁·沙可在神经学领域的视觉艺术。
Arch Neurol. 1991 Apr;48(4):421-5. doi: 10.1001/archneur.1991.00530160091020.
9
Jean-Martin Charcot's role in the 19th century study of music aphasia.让-马丁·沙可在 19 世纪音乐性失语症研究中的作用。
Brain. 2013 May;136(Pt 5):1662-70. doi: 10.1093/brain/awt055. Epub 2013 Apr 9.
10
Poor Beard!! Charcot's internationalization of neurasthenia, the "American disease".可怜的比尔德!!夏科将神经衰弱这一“美国病”进行了国际化推广。
Neurology. 2001 Aug 14;57(3):510-4. doi: 10.1212/wnl.57.3.510.